Medinotec (MDNC) Price to Sales (2023 - 2026)

Medinotec (MDNC) has reported Price to Sales for 4 consecutive years, with 22.17 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Sales fell 19.5% year-over-year to 22.17; the trailing twelve-month figure through May 2026 stood at 5.74 (down 2.13% YoY), and the FY2026 full-year result was 6.04, down 6.16% from the prior year.
• Price to Sales retreated to 22.17 in Q2 2026 per MDNC's latest filing, from 32.26 in the prior quarter.
• Across five years, Price to Sales topped out at 167.25 in Q3 2023 and bottomed at 16.64 in Q1 2025.
• Historically, Price to Sales has averaged 38.73 across 4 years, with a median of 26.8 in 2024.
• The sharpest annual moves came in 2024 and 2026: Price to Sales sank 80.55% in 2024, then surged 93.82% in 2026.
• Over 4 years, Price to Sales stood at 29.3 in 2023, then slipped by 21.93% to 22.87 in 2024, then grew by 1.29% to 23.17 in 2025, then retreated by 4.3% to 22.17 in 2026.
• According to Business Quant data, Price to Sales over the past three periods registered 22.17, 32.26, and 23.17 for Q2 2026, Q1 2026, and Q4 2025 respectively.